USING THE ACCUVEIN DEVICE FOR PATIENTS WHO ARE DIFFICULT TO PERFUSE (VAV-AV)

University Hospital, Rouen

Status

Not yet enrolling

Conditions

Patient Who Are Difficult to Infuse

Treatments

Other: with out accuvein

Device: accuvein

Study type

Interventional

Funder types

Other

Identifiers

NCT06861595

2022/0357/HP

Details and patient eligibility

About

Prior to any examination related to the clinical investigation, the investigator (IDE) will check the eligibility criteria of the person undergoing the research, and will inform and obtain the free, informed and written consent of the person undergoing the research.

The patient will then be randomised into one of two groups (insertion of a intravenous route with the AccuVein device vs. insertion of a VVP without the AccuVein device). After randomisation, the TEC or qualified person starts the stopwatch as soon as the tourniquet is applied.

The nurse makes a first attempt to perfuse the patient. The TEC or the qualified person will stop the stopwatch when the nurse checks the patency of the first attempt at perfusion and signals its success, or when the nurse withdraws the needle if the first attempt is unsuccessful. The pain felt by the patient will be assessed by the nurse using the self-assessment scale from 0 to 10 at the end of the first attempt.

If the first attempt at VVP insertion fails, the choice of conditions and personnel involved in carrying out further attempts will be left to the discretion of the nurse.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age ≥ 18 years
Patients who are difficult to infuse according to the nurse's subjective assessment after the tourniquet has been applied; this may particularly concern patients who are obese, dark-skinned, multi-drug users, sickle-cell anaemia sufferers, drug addicts, elderly with fragile skin and subcutaneous haematomas
Patients with a medical prescription for intravenous route
Patients affiliated to a social security scheme
For women of childbearing age: effective contraception (oral contraceptives, intra-uterine devices or condoms) or post-menopausal women (no menstrual period for 12 months).
Patient has read and understood the information letter and signed the consent form

Exclusion criteria

Contraindication to fitting a intravenous route (burns to all four limbs, etc.)
Extreme urgency to have a intravenous route, incompatible with the study, because of a loss of chance due to loss of time
Patients unable to consent to participation in research
Pregnant or breastfeeding women or women in labour
Person deprived of liberty by administrative or judicial decision or person placed under court protection/guardianship or curatorship